Synthesize Bio logo

Synthesize Bio

Synthesize Bio is a Seattle-based biotech startup that leverages artificial intelligence to accelerate drug discovery, distinguishing...

Facts

HQ
Seattle, WA, US
Sectors
Biotechnology Research
Founded
2023
Type
Corporation Seattle business license
Employees
21
Registered name
Synthesize Bio Seattle business license
Stage
Seed
Founders
Robert Bradley, PhD, Jeff Leek, PhD

Recent coverage

Front-page news, podcasts and videos about Synthesize Bio

See all 13

AI House hosts Demo Day in Seattle with 25 startups pitching to investors flown in from Boston, New York, Colorado and the Bay Area

AI House hosted a demo day in Seattle where 25 early-stage startups—many outside the incubator’s portfolio—pitched to investors flown in from Boston, New York, Colorado, the Bay Area and other cities to increase outside capital for local founders. Organizers aimed to showcase diverse Seattle startups, from revenue-generating companies to ambitious technologists, and attracted both national and local venture investors.

Seattle Startup Pauling.AI Uses AI to Cut Drug Discovery from Months to Weeks, Founded by Ex-Google Exec Javier Tordable in 2024

Seattle startup Pauling.AI uses AI to automate early drug discovery steps, reducing timelines from months to weeks and aiming to greatly increase new drug approvals. Founded in 2024 by former Google technical director Javier Tordable, the company offers a 'scientist-as-a-service' platform to assist researchers with computational chemistry and drug candidate modeling.

People

Online